Estimating the False-Positive Rate of Highly Automated SARS-CoV-2 Nucleic Acid Amplification Testing.
作者信息
Chandler Christopher M, Bourassa Lori, Mathias Patrick C, Greninger Alexander L
机构信息
Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA.
Department of Biomedical Informatics and Medical Education, University of Washington School of Medicine, Seattle, Washington, USA.
出版信息
J Clin Microbiol. 2021 Jul 19;59(8):e0108021. doi: 10.1128/JCM.01080-21.
Abstract
摘要
相似文献
1
Estimating the False-Positive Rate of Highly Automated SARS-CoV-2 Nucleic Acid Amplification Testing.估算高度自动化的严重急性呼吸综合征冠状病毒2核酸扩增检测的假阳性率。
J Clin Microbiol. 2021 Jul 19;59(8):e0108021. doi: 10.1128/JCM.01080-21.
2
Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting.低流行地区 SARS-CoV-2 核酸扩增检测的特异性和阳性预测值。
Clin Microbiol Infect. 2021 Mar;27(3):469.e9-469.e15. doi: 10.1016/j.cmi.2020.10.003. Epub 2020 Oct 14.
3
Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays.使用赛沛Xpert Xpress SARS-CoV-2检测系统和罗氏cobas SARS-CoV-2检测法检测严重急性呼吸综合征冠状病毒2（SARS-CoV-2）
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00772-20.
4
Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.雅培 ID Now COVID-19 快速核酸扩增检测试剂使用鼻咽拭子和干鼻拭子在纽约市学术机构中运输的病毒运输介质的性能。
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01136-20.
5
A study of quality assessment in SARS-CoV-2 pathogen nucleic acid amplification tests performance; from the results of external quality assessment survey of clinical laboratories in the Tokyo Metropolitan Government external quality assessment program in 2020.一项关于 SARS-CoV-2 病原体核酸扩增检测性能的质量评估研究；来自 2020 年东京都政府临床实验室外部质量评估计划外部质量评估调查的结果。
J Infect Chemother. 2022 Feb;28(2):242-247. doi: 10.1016/j.jiac.2021.10.027. Epub 2021 Nov 10.
6
Development and comparison of novel multiple cross displacement amplification (MCDA) assays with other nucleic acid amplification methods for SARS-CoV-2 detection.新型多重交叉置换扩增（MCDA）检测方法与其他核酸扩增方法在 SARS-CoV-2 检测中的开发与比较。
Sci Rep. 2021 Jan 21;11(1):1873. doi: 10.1038/s41598-021-81518-8.
7
High-Throughput Transcription-mediated amplification on the Hologic Panther is a highly sensitive method of detection for SARS-CoV-2.Hologic Panther 上的高通量转录介导扩增是一种高度敏感的 SARS-CoV-2 检测方法。
J Clin Virol. 2020 Aug;129:104501. doi: 10.1016/j.jcv.2020.104501. Epub 2020 Jun 10.
8
Development and Clinical Application of a Rapid and Sensitive Loop-Mediated Isothermal Amplification Test for SARS-CoV-2 Infection.用于 SARS-CoV-2 感染的快速灵敏环介导等温扩增检测方法的建立与临床应用。
mSphere. 2020 Aug 26;5(4):e00808-20. doi: 10.1128/mSphere.00808-20.
9
Comparison of commercial assays and laboratory developed tests for detection of SARS-CoV-2.商业检测试剂盒与实验室自建检测方法用于 SARS-CoV-2 检测的比较。
J Virol Methods. 2020 Nov;285:113970. doi: 10.1016/j.jviromet.2020.113970. Epub 2020 Sep 10.
10
SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment.新型冠状病毒核酸检测是中国防控新冠肺炎疫情的关键支柱。
Lancet. 2022 Apr 30;399(10336):1690-1691. doi: 10.1016/S0140-6736(22)00577-3. Epub 2022 Apr 7.
引用本文的文献
1
Use of a Multiplex Immunoassay Platform to Investigate Multifaceted Antibody Responses in SARS-CoV-2 Vaccinees with and Without Prior Infection.使用多重免疫分析平台研究有或无既往感染的新冠病毒疫苗接种者的多方面抗体反应。
COVID. 2025 Apr;5(4). doi: 10.3390/covid5040044. Epub 2025 Mar 22.
2
Testing for SARS-CoV-2: lessons learned and current use cases.SARS-CoV-2 检测：经验教训和当前应用案例。
Clin Microbiol Rev. 2024 Jun 13;37(2):e0007223. doi: 10.1128/cmr.00072-23. Epub 2024 Mar 15.
3
Pre-Operative SARS-CoV-2 Testing in Asymptomatic Heart Transplantation Recipients.无症状心脏移植受者的术前新型冠状病毒2检测
Biomedicines. 2023 Jul 26;11(8):2103. doi: 10.3390/biomedicines11082103.
4
Sensitivity and Diagnostic Yield of the First SARS-CoV-2 Nucleic Acid Amplification Test Performed for Patients Presenting to the Hospital.首诊于医院患者的 SARS-CoV-2 核酸扩增检测的灵敏度和诊断收益。
JAMA Netw Open. 2022 Oct 3;5(10):e2236288. doi: 10.1001/jamanetworkopen.2022.36288.
5
Rapid Antigen Assays for SARS-CoV-2: Promise and Peril.用于 SARS-CoV-2 的快速抗原检测：前景与风险。
Clin Lab Med. 2022 Jun;42(2):203-222. doi: 10.1016/j.cll.2022.03.001. Epub 2022 Mar 4.
6
Biosensor detection of airborne respiratory viruses such as SARS-CoV-2.生物传感器检测空气中的呼吸道病毒，如 SARS-CoV-2。
SLAS Technol. 2022 Feb;27(1):4-17. doi: 10.1016/j.slast.2021.12.004. Epub 2022 Jan 2.
7
Implementation of the Abbott ID Now COVID-19 assay at a tertiary care center: a prospective pragmatic implementation study during the third wave of SARS-CoV-2 in Ontario.在安大略省 SARS-CoV-2 第三波疫情期间，于一家三级护理中心实施雅培 ID Now COVID-19 检测：一项前瞻性实用实施研究。
Diagn Microbiol Infect Dis. 2022 Mar;102(3):115609. doi: 10.1016/j.diagmicrobio.2021.115609. Epub 2021 Nov 27.
8
SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic : Conclusions for crisis response at a high-volume oncology center.SARS-CoV-2 筛查在癌症门诊患者在 COVID-19 大流行的第二波：危机应对的结论在一个高容量的肿瘤中心。
Wien Klin Wochenschr. 2021 Sep;133(17-18):909-914. doi: 10.1007/s00508-021-01927-7. Epub 2021 Aug 19.
9
Test it earlier, result it faster, makes us stronger: how rapid viral diagnostics enable therapeutic success.检测得更早，结果更快，让我们更强：快速病毒诊断如何实现治疗成功。
Curr Opin Virol. 2021 Aug;49:111-116. doi: 10.1016/j.coviro.2021.05.007. Epub 2021 Jun 8.
本文引用的文献
1
Two cases of novel coronavirus infection (COVID-19) with transient viral elevation using semi-quantitative real-time reverse transcription PCR and symptom relapse after completion of 10 days of favipiravir treatment.两例新型冠状病毒感染（COVID-19）患者，使用半定量实时逆转录聚合酶链反应（RT-PCR）检测病毒载量短暂升高，在完成 10 天的法匹拉韦治疗后症状复发。
J Infect Chemother. 2021 Jul;27(7):1072-1075. doi: 10.1016/j.jiac.2020.12.018. Epub 2020 Dec 23.
2
Experience With False-Positive Test Results on the TaqPath Real-Time Reverse Transcription-Polymerase Chain Reaction Coronavirus Disease 2019 (COVID-19) Testing Platform.TaqPath实时逆转录-聚合酶链反应2019冠状病毒病（COVID-19）检测平台假阳性检测结果的经验
Arch Pathol Lab Med. 2021 Mar 1;145(3):259-261. doi: 10.5858/arpa.2020-0612-LE.
3
Comparison of Commercially Available and Laboratory-Developed Assays for Detection of SARS-CoV-2 in Clinical Laboratories.临床实验室中用于检测新型冠状病毒2的商用检测方法与实验室自行开发检测方法的比较
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00821-20.
4
Validation of laboratory-developed molecular assays for infectious diseases.传染病的实验室研发分子检测的验证。
Clin Microbiol Rev. 2010 Jul;23(3):550-76. doi: 10.1128/CMR.00074-09.
Zotero 插件